QUCY

Mainz Biomed N.V.

There isn't enough reported data to score QUCY yet.

QUCY Fundamentals

MetricStatus
Unavailable
Weak
Unavailable
Unavailable

QUCY's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.

QUCY PE Valuation

QUCY has no meaningful PE right now: it lost money over the past year.

QUCY Forward outlook

MetricOutlook
--
Losses shrinking
Strong decline
--
Limited
High

Analysts expect QUCY's losses to shrink, with revenue declining.

QUCY Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $0.56 on Nov 12.

There is not enough scenario data to assess QUCY's risk to reward.

QUCY Earnings Per Share

Q1 2026: $-1.70Q2 2026: $-1.94Q3 2026: $-1.57
Q1 2026: $-1.70Q2 2026: $-1.94Q3 2026: $-1.57

QUCY Quarterly Revenue

Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: $286,717Q3 2025: $125,180Q4 2025: $125,180Q1 2026: --Q2 2026: --Q3 2026: $966,833
Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: $286,717Q3 2025: $125,180Q4 2025: $125,180Q1 2026: --Q2 2026: --Q3 2026: $966,833
QuarterRevenueYoY
Q3 2026$966.8K+672%

QUCY Free Cash Flow

Q4 2023: −$5MQ1 2024: −$4MQ2 2024: −$4MQ3 2024: −$5MQ4 2024: −$5MQ1 2025: −$4MQ2 2025: −$3MQ3 2025: −$2MQ4 2025: −$2MQ1 2026: −$3MQ2 2026: −$7MQ3 2026: −$4M
Q4 2023: −$5MQ1 2024: −$4MQ2 2024: −$4MQ3 2024: −$5MQ4 2024: −$5MQ1 2025: −$4MQ2 2025: −$3MQ3 2025: −$2MQ4 2025: −$2MQ1 2026: −$3MQ2 2026: −$7MQ3 2026: −$4M
QuarterFree cash flowYoY
Q3 2026-$4.3M-$2M
Q2 2026-$7.3M-$4.5M
Q1 2026-$2.7M+$1.4M
Q4 2025-$2.2M+$2.4M
Q3 2025-$2.2M+$2.4M
Q2 2025-$2.8M+$1.3M
Q1 2025-$4.1M-$10.6K
Q4 2024-$4.6M+$232.6K

QUCY has burned cash in almost every quarter: −$17M over the past year, against −$14M the year before.

QUCY Total Shares

Q2 2025: 9MQ3 2025: 9MQ4 2025: 9MQ1 2026: 12MQ2 2026: 18MQ3 2026: 64M
Q2 2025: 9MQ3 2025: 9MQ4 2025: 9MQ1 2026: 12MQ2 2026: 18MQ3 2026: 64M
PeriodChange %Net change
Quarterly+257%+45.8M shares
1 year+620%+54.8M shares

QUCY has 64M diluted shares, up 620% from a year ago.

QUCY Net Leverage

QUCY's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

QUCY Weekly Momentum

MetricValueStatus
RSI35.1Neutral
Stochastic3.7Oversold

QUCY's weekly RSI is 35 (neutral) and its Stochastic is 4 (oversold).

QUCY PE vs Healthcare Sector

QUCY has no meaningful PE right now: it lost money over the past year.

QUCY Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$1.0346% below
20 week MA$1.2254% below
50 week MA$1.2053% below
100 week MA$2.0473% below
200 week MA$48.999% below

QUCY is in a downtrend: it's below all five of its weekly moving averages, and 99% below its 200-week average.

QUCY Yearly ROI

YearStart priceEnd priceROI
2021$399.6$417.6+4.5%
2022$417.6$286.8-31%
2023$286.8$46.4-84%
2024$46.4$4.60-90%
2025$4.60$1.27-72%
2026 YTD$1.27$0.56-56%

QUCY has finished four years in a row lower, and it's down 56% so far in 2026.

Give your agent the market.

Get API key